The Widal test is a blood test used to help diagnose typhoid and paratyphoid fever. It works by detecting antibodies your immune system produces in response to Salmonella Typhi, the bacterium that causes typhoid. The test has been around for over a century and remains widely used in developing countries because it’s inexpensive and doesn’t require sophisticated lab equipment, though it has well-documented accuracy limitations.
How the Test Works
When Salmonella Typhi infects your body, your immune system produces antibodies that target specific parts of the bacterium. The Widal test looks for two types of these antibodies in a sample of your blood. The first targets the outer surface of the bacterium (called the O antigen), and the second targets its whip-like tail used for movement (called the H antigen). During the test, a technician mixes your blood serum with a preparation of killed Salmonella cells. If the matching antibodies are present, the bacterial cells visibly clump together, a reaction called agglutination.
These two antibody types tell your doctor slightly different things. O antibodies appear first during an active infection, rise as the illness progresses, and typically disappear within a few months after recovery. H antibodies show up a little later but stick around much longer. A rising O antibody level generally points to a current, active infection, while the H antibody pattern helps identify which specific type of enteric fever you have.
Slide Method vs. Tube Method
There are two main ways the test is performed. The slide method is faster: a technician places a drop of your serum on a glass slide, mixes it with the antigen preparation, and rocks the slide gently for about two minutes. If clumping appears, the test is considered reactive. This method gives a quick preliminary result but is less precise.
The tube method is more detailed and considered more reliable. Your serum is diluted to different concentrations in a series of test tubes, each mixed with the bacterial antigen. After an incubation period, the technician checks which dilutions still show clumping. The highest dilution that produces visible agglutination is your “titer,” the number that appears on your results.
What Your Results Mean
Widal test results are reported as a titer, written as a ratio like 1:80, 1:160, or 1:320. The higher the number, the more antibodies are circulating in your blood. In one study of confirmed typhoid cases, 70% of patients had O antibody titers at or above 1:160, compared to only 3% of healthy controls. Based on these findings, an O or H titer of 1:160 or higher is generally considered suggestive of typhoid infection.
However, interpreting a single result is not straightforward. The most reliable approach is testing twice: once when symptoms begin and again one to two weeks later. A fourfold rise in titer between the two samples is strong evidence of active infection. A single high reading, on its own, can be misleading for reasons explained below.
Why Timing Matters
The Widal test performs poorly in the first few days of illness. Your immune system needs time to build up detectable levels of antibodies, and blood drawn too early will often come back negative even when typhoid is present. Research has shown that antibody levels typically become detectable only after three or more days of fever. Testing before that window frequently produces false negatives, simply because the body hasn’t mounted a strong enough immune response yet.
Accuracy and Limitations
Compared to blood culture, which is the gold standard for confirming typhoid, the Widal test has moderate accuracy at best. In a comparative study, the test showed a sensitivity of about 70% and a specificity of about 74%. That means it misses roughly 30% of true typhoid cases and incorrectly flags about 26% of people who don’t actually have the infection.
The test’s positive predictive value, the chance that a positive result truly means you have typhoid, was only about 31% in that study. Its negative predictive value was much better at around 94%, meaning a negative result is fairly reliable for ruling typhoid out. In practical terms, a negative Widal test is more trustworthy than a positive one.
False Positives
Several conditions can trigger a positive Widal result even when typhoid isn’t present. Malaria is one of the most common culprits in tropical regions. The malaria parasite stimulates a broad, nonspecific immune response that can produce antibodies reacting with the typhoid antigens used in the test. Other infections linked to false positives include tuberculosis, dengue, brucellosis, and bacterial endocarditis. Chronic liver disease can also cause misleading results.
Previous typhoid vaccination is another source of confusion. If you’ve been vaccinated, your H antibodies may remain elevated for months or years, making it look like you have an active infection when you don’t.
The Problem in Endemic Regions
Interpretation becomes especially tricky in areas where typhoid is common. In endemic regions, many healthy people carry low levels of Salmonella antibodies from past exposure, even if they were never seriously ill. These background antibody levels, known as the baseline titer, vary widely between regions and even between neighborhoods depending on local sanitation conditions and vaccination rates.
A titer of 1:160 might be clearly abnormal in a population with minimal typhoid exposure, but perfectly normal in a community where most people have encountered the bacterium before. For this reason, each region ideally needs its own established baseline titer to interpret results correctly. Without knowing the local baseline, a doctor cannot confidently distinguish between a past exposure and an active infection from a single blood draw. These baselines also shift over time as sanitation infrastructure and vaccination coverage change, so they need regular updating.
Where the Widal Test Still Fits
Despite its limitations, the Widal test remains the primary typhoid diagnostic tool in many resource-limited settings across South Asia, Sub-Saharan Africa, and Southeast Asia. Blood culture requires specialized equipment, trained staff, and 48 to 72 hours to produce results. The Widal test costs a fraction of the price and can deliver results within hours or even minutes with the slide method.
That said, a 2025 review published in the Journal of Public Health in Africa concluded that the Widal test “should not be used for diagnosing or guiding the management of patients” with nonspecific fever symptoms in endemic regions, given its cross-reactivity with other common febrile illnesses. The review recommended newer rapid tests as alternatives until more affordable point-of-care diagnostics become available. The World Health Organization has emphasized that an ideal typhoid test for low-resource settings should be sensitive, specific, affordable, and rapid, criteria the Widal test only partially meets.
Where it is still used, combining the Widal test with clinical assessment and, when possible, blood culture gives the most reliable picture. Relying on a single Widal result alone to start or withhold treatment carries a meaningful risk of error in either direction.